Biotech

All Articles

Biogen's CEO stated no risky deals in 2023. He's ready to be strong

.While Biogen's pharma peers are actually searching for late-stage properties with little risk, chie...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has actually been actually a biotech looking for a pipe after it scrapped its own ...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back rights to a very early Alzheimer's health condition system to Denali Therapi...

Takeda faucets brand-new head of US oncology organization-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings and r...

Vertex, hammered through AATD once again, drops 2 properties on throw away stack

.Tip's effort to deal with a rare hereditary health condition has actually struck another misfortune...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of personnel

.Vir Medical's second-quarter revenues document wasn't except significant updates. The company invit...

Galapagos pauses CAR-T tissue therapy litigation over Parkinsonism case

.Galapagos has actually paused registration in a trial of a BCMA-directed CAR-T cell therapy, pumpin...

James Wilson leaving behind Penn to introduce pair of brand-new biotechs

.After much more than three decades, genetics therapy trendsetter James Wilson M.D., Ph.D., is actua...

3 biotechs attempt to trump the summertime heat energy through shedding personnel

.As biotechs seek to switch a new web page in August, at least three firms have shed personnel in tr...

venBio elevates $528M for fifth life scientific researches VC fund

.Pro venture capital agency venBio has actually elevated one more half a billion bucks to buy biotec...